Initial dose of oncolytic myxoma virus programs durable antitumor immunity independent of in vivo viral replication
Crossref DOI link: https://doi.org/10.1136/jitc-2020-000804
Published Online: 2020-06-24
Published Print: 2020-06
Update policy: https://doi.org/10.1136/crossmarkpolicy
Flores, Erica B
Aksoy, Bulent A
Bartee, Eric http://orcid.org/0000-0003-1793-446X
Funding for this research was provided by:
NIH (R01CA194090, R21AI142387)
American Cancer Society (RSG-17-047-01-MPC)
License valid from 2020-06-24